Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell types, including but not limited to osteoblasts, chondrocytes, myocytes, and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cells types for a variety of reasons, including that they are immuno-privileged, making them an advantageous cell type for allogenic transplantation. [Read more…]
Mesenchymal Stem Cells (MSCs)
Mesenchymal stem cells (MSCs) are a well-characterized population of adult stem cells that can differentiate into a variety of cell types (chondrocytes, osteoblasts, adipocytes, myocytes, and more).
The Little Known History of MSCs (Year-By-Year)
Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, and adipocytes. MSCs are of intense therapeutic interest, because they represent a population of cells with the potential to treat a range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for a variety of reasons, including that they are immunoprivileged, making them an advantageous cell type for allogeneic transplantation.
Allogeneic means that cells from a donor are used in the treatment of a different person.Â
Overview of Mesenchymal Stem Cells (MSCs)
In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are also advantageous over other stem cells types, because they avoid the ethical issues that surround embryonic stem cell research and can positively impact immune function. Because of their unique capacity to form structural tissues, MSCs also being explored for use in 3D printing applications.
History of Mesenchymal Stem Cells (MSCs)
1900s
The discovery of mesenchymal stem cells (MSCs) dates back to the early 1900’s.
1924
In 1924, the Russian-born researcher Alexander Maximow used histology to identify a type of precursor cell within the mesenchyme that could differentiate into a variety of blood cell types.[1] While the term mesenchymal stem cell did not exist, this is the earliest known reference to the cell type.
1960s
Nearly 40 years later, in the 1960’s, researchers Ernest McCulloch and James Till identified the clonal qualities of marrow cells. [2],[3] It then took another decade until an ex vivo assay was developed that allowed for examination of the clonal nature of multipotent marrow cells.[4] [Read more…]
Kexing Biopharm’s Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Registered with FDA DMF
SHENZHEN, China, Sept. 16, 2025 — Kexing Biopharm announced that its investigational Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes has successfully completed a Type II Drug Master File (DMF) registration with the U.S. FDA.
Exosomes, as a next-generation bioactive carrier, boast unique advantages such as low immunogenicity, strong tissue penetration, and potential for targeted modification, offering immense promise for medical applications. However, the technical barriers and research challenges in Exosome development place them at the forefront of complexity among bioactive material fields. [Read more…]
Exploring Advanced Therapies in Diabetes Treatment: A Glimpse into the Future
Diabetes is a chronic condition affecting millions globally, characterized by high blood sugar levels due to the body’s inability to produce or effectively use insulin. Traditional management strategies, including lifestyle modifications and medications, have been vital in controlling diabetes, but they often fall short of addressing the disease’s complexities and long-term complications. In recent years, advanced therapies have emerged, offering new hope for patients.
These therapies encompass innovations such as regenerative medicine, advanced insulin delivery systems, and gene editing technologies, each bringing us closer to more effective and personalized treatments. [Read more…]
MSCs as a Pivotal Tool for Cell Therapy, Gene Therapy, and Tissue Engineering
MSCs have many fascinating properties, including strong immunomodulatory effects, the ability to repair damaged tissues, and the capacity in vitro to differentiate into other cells types. These traits, combined with their easy availability from different sources, has prompted researchers to look at MSCs as promising raw materials for use in cell therapy, gene therapy, and tissue engineering, the three pillars of regenerative medicine. The cumulative efforts of scientists, researchers and life science companies have resulted in the approval of 12 MSC-based cell therapies (several of which have been approved in multiple regions) and 19 MSC-based bone matrices. [Read more…]
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 59
- Next Page »